TickerFactsScreenerDevelopers

Matinas BioPharma Holdings, Inc. (MTNB) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $94.2K2014: $288.5K2015: $76.2K2016: $02017: $942.2K2018: $535.9K2019: $405.6K2020: $5.7K2021: $260.0K2022: $892.0K2023: $218.0K$218.0K
2013Capital Expenditures (USD)2023
Fiscal YearCapital ExpendituresChange YoY
2023$218.0K-75.6%
2022$892.0K+243.1%
2021$260.0K+4422.5%
2020$5.7K-98.6%
2019$405.6K-24.3%
2018$535.9K-43.1%
2017$942.2K—
2016$0-100.0%
2015$76.2K-73.6%
2014$288.5K+206.3%
2013$94.2K—